Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines

about

Screening and prevention for latent tuberculosis in immunosuppressed patients at risk for tuberculosis: a systematic review of clinical practice guidelines

Item

http://www.wikidata.org/entity/Q58746309

description

scientific article published on 12 September 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у вересні 2018

@uk

name

Screening and prevention for l ...... f clinical practice guidelines

@en

Screening and prevention for l ...... f clinical practice guidelines

@nl

type

Item

label

Screening and prevention for l ...... f clinical practice guidelines

@en

Screening and prevention for l ...... f clinical practice guidelines

@nl

prefLabel

Screening and prevention for l ...... f clinical practice guidelines

@en

Screening and prevention for l ...... f clinical practice guidelines

@nl

P1476

Screening and prevention for l ...... f clinical practice guidelines

@en

P2093

Germaine Wong

http://www.w3.org/2001/XMLSchema#string

Sharon Chen

http://www.w3.org/2001/XMLSchema#string

Tasnim Hasan

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective

Saudi guidelines for testing and treatment of latent tuberculosis infection

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registry.

Improving the estimation of tuberculosis infection prevalence using T-cell-based assay and mixture models

AGREE II: advancing guideline development, reporting and evaluation in health care.

Management of rheumatoid arthritis: consensus recommendations from the Hong Kong Society of Rheumatology

The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.

BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment

Controlling tuberculosis in the United States. Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America.

National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents.

P304

e022445

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BMJOPEN-2018-022445

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Allison Tong

Eric H K Au

P577

2018-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30209157

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

immunosuppression

P932

6144320

http://www.w3.org/2001/XMLSchema#string